INTERNATIONAL SOCIETY FOR      DISEASES OF THE ESOPHAGUS

  • Home
  • Cancer Prevention Lessons from the Oesophagus using Aspirin

Cancer Prevention Lessons from the Oesophagus using Aspirin

  • 03 Nov 2014
  • 10:00 AM - 11:00 AM (PST)
  • Webinar

Registration


Registration is closed
Cancer Prevention Lessons from the Oesophagus using Aspirin
 

Barrett's esophagus is a very common premalignant lesion affecting between 2-3% of the adult population in the West. As a consequence strategies have evolved to attempt to abrogate the progression along the metaplasia-dysplasia-adenocarcinoma sequence. Several strategies including earlier detection, screening and surveillance have an unproven efficacy. As a consequence the role of chemoprevention agents (drugs which can prevent cancer) has come to the fore. The prime agent is aspirin but the risk-benefit ratio remains unclear. In addition it isn't clear who will respond best and who will be destined for life threatening complications. Genomics may be able to tease this out.

 

Presenter:
Prof. Janusz Jankowski, MD
Health and Life Sciences
Coventry University, UK

 


 


© International Society for Diseases of the Esophagus 2016

Powered by Wild Apricot Membership Software